Therefore, YY1 regulates several signaling pathways, including the inhibition of p53 and miR34a, the activation of the PI3K/Akt/mTOR pathway, as well as c-Myc and COX-2 [96] involved in tumor resistance to ICIs. This evidence concerns the gene AKT1 and neoplasm.